GO
Loading...

Covidien PLC

More

  • Medical M&A: Who's next?     Monday, 16 Jun 2014 | 10:13 AM ET

    Medtronic announced it will buy Covidien for $42.9 billion. Barbara Ryan of FTI Consulting, discusses consolidation in the medical industry.

  • Medtronic to buy Covidien     Monday, 16 Jun 2014 | 10:10 AM ET

    CNBC's Meg Tirrell provides insight to Medtronic's announcement it will buy Covidien, and also discusses the consolidation trends in medical device companies.

  • Medtronic’s $43B Covidien deal: More to come? Monday, 16 Jun 2014 | 9:26 AM ET
    Medtronic Chairman and Chief Executive Omar Ishrak.

    Medtronic's $43 billion Covidien deal may signal future medical-device company mergers.

  • US STOCKS-Wall St to open lower on Iraq turmoil Monday, 16 Jun 2014 | 9:02 AM ET

    *U.S. considering talks with Iran over Iraq. *Medtronic to buy Covidien for $42.9 bln. *Geopolitical tensions in Ukraine also flared as Russian natural gas exporter Gazprom reduced supplies to Ukraine after Kiev failed to meet a deadline to pay off its gas debts in a dispute that could disrupt supplies to the rest of Europe.

  • Medtronic is buying Covidien in a $42.9 billion agreement that could increase concerns about the rush of U.S. companies striking deals to cut their tax bills.

  • Bill George, Harvard business professor and former Medtronic CEO, shares his thoughts on Medtronic's $43 billion deal to buy the medical device maker for $93.22 per share.

  • Early Movers: COV, YHOO, GOOG, GE, TGT, T & more Monday, 16 Jun 2014 | 7:46 AM ET
    Traders work the floor of the New York Stock Exchange.

    Some of the names on the move ahead of the open.

  • US STOCKS-Futures drop as Iraq turmoil continues Monday, 16 Jun 2014 | 7:40 AM ET

    *U.S. considering talks with Iran over Iraq. *Medtronic to buy Covidien for $42.9 bln. *Geopolitical tensions in Ukraine also flared as Russian natural gas exporter Gazprom reduced supplies to Ukraine on Monday after Kiev failed to meet a deadline to pay off its gas debts in a dispute that could disrupt supplies to the rest of Europe.

  • CNBC's Meg Tirrell reports the latest detail on the deal as consolidation in the health care industry continues.

  • June 15- U.S. medical device maker Medtronic Inc said on Sunday it had agreed to buy Covidien Plc for $42.9 billion in cash and stock and move its executive base to Ireland in the latest transaction aiming for lower corporate tax rates abroad.

  • June 15- U.S. medical device maker Medtronic Inc said on Sunday it would buy Covidien Plc for $42.9 billion in cash and stock, moving its executive base to Ireland in the latest transaction to seek lower corporate tax rates abroad.

  • June 14- U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.

  • June 14- Medical-device maker Medtronic Inc and rival Covidien Plc are in advanced talks to combine in a deal valued at $45 billion to $50 billion, a source familiar with the matter said on Saturday.

  • June 14- U.S. medical device maker Medtronic Inc is in advanced talks to merge with rival Covidien Plc in a deal valued at between $45 billion and $50 billion, a person familiar with the matter said on Saturday.

  • Medtronic, Covidien in advanced talks to combine -WSJ Saturday, 14 Jun 2014 | 12:23 PM ET

    June 14- Medical-device maker Medtronic Inc and rival Covidien PLC are in advanced talks to combine in a deal that could be worth more than $40 billion, the Wall Street Journal reported on Saturday, citing people familiar with the matter. Covidien is based in Ireland, which is known for having a relatively low tax rate.

  • NEW YORK, June 9- When the European Central Bank put its economy-boosting stimulus plan into high gear last week, it sent European stock prices to six-year highs.

  • JPMorgan health care pro's top stock picks Monday, 21 Apr 2014 | 7:00 PM ET

    JPMorgan Chase's Mike Weinstein gives his top health care picks to buy right now, in light of recent weakness in the sector.

  • April 15- ConMed Corp, a surgical device maker that has been fighting off activist investors, is exploring a sale and has contacted large medical device companies to gauge their buyout interest, people familiar with the matter said on Tuesday.

  • Mallinckrodt pullback a buying opportunity? Monday, 7 Apr 2014 | 6:46 PM ET

    When shares of a good company fall swiftly, Cramer looks to see if the pullback presents opportunity.

  • April 7- Specialty pharmaceuticals company Mallinckrodt Plc will buy drugmaker Questcor Pharmaceuticals Inc for about $5.6 billion to gain access to its lucrative drug to treat multiple sclerosis, Acthar Gel.